(BDS) has been developed and tested by the world’s leading
breast cancer specialists.
It has been developed to make mammograms
and all other current breast cancer diagnostic technologies obsolete
in the next generation.
What separates (BDS) from mammograms and other leading cancer diagnostic
technology is its accuracy level. (BDS) can detect up to 30% of
cancers (especially smaller tumors in the earlier stages) missed
by mammograms. It is totally non-evasive and painless causing women
to no longer undergo unnecessary biopsies, which may be what deters
some women from seeking early detection in the first place.
(BDS) technology is far more effective than mammograms and other
forms of breast cancer diagnostic technology for a number of reasons
including:
- Accuracy: (BDS) can detect up to 30% of cancers (especially
small tumors)
missed by mammograms.
- Safe & Painless: (BDS) is non-evasive, painless and radiation
free and the procedure may be repeated as frequently as desired.
Eliminating unnecessary biopsies, which up until now may have attributed
to women not seeking early detection in the first place.
- Portability: (BDS) can be used in a physician’s office
yet small enough to transport to rural areas creating options
for women who have up to now could only go to more populated areas
and visit a hospital or major medical centers for their screenings.
- Rapid Results: (BDS) will provide accurate results immediately.
(15 minutes) and a trained technician rather than a physician or radiologist can perform the procedure.
- Cost to patient: (BDS) is ten times less expensive than mammograms,
ultrasound,
CT scans and MRIs.
- Cost to Physician: (BDS) is profitable to the physician yet
testing can be priced lower than diagnostic mammography and screening
mammograms, with no expensive training or other lab fees.
|
| |
|
About Us
The Biofield Diagnostic System